Tadayoshi Hirata

Tadayoshi Hirata is a Senior Investment Manager at Astellas Venture Management LLC, where he directs early-stage biotechnology investments across the global healthcare sector. Prior to transitioning into this corporate venture capital role, he built his industry background by working directly within Astellas Pharma US, Inc. In his current capacity as an investment lead, he specifically targets privately owned startups that are developing novel therapeutics programs and advanced platform technologies for drug discovery. In 2023, Hirata co-led a financing round in Mogrify alongside Parkwalk Advisors, which successfully extended the regenerative medicine company's Series A funding to $46 million. This transaction built upon an existing 2022 collaboration between Astellas Pharma Inc. and Mogrify targeting sensorineural hearing loss. His ongoing focus centers on deploying strategic capital to accelerate the development of in vivo reprogramming therapies and early-stage biotech platforms.